Aggiornamento
La psoriasi in età pediatrica
Psoriasis in childhood
Prisca Da Lozzo1, Lorenzo Calligaris2, Irene Berti2
1Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste
2IRCCS Materno-Infantile “Burlo Garofolo”, Trieste
Marzo 2020 - pagg. 154 -160
Abstract
Psoriasis is a chronic immune-mediated inflammatory skin disorder with a relapsing
course and a multifactorial pathogenesis. Several triggers, genetic factors and comorbid
conditions are associated and are likely to be involved in the increasing incidence of the
disease. Psoriasis begins in childhood in almost one-third of the cases. Although children
present with the same clinical subtypes of psoriasis observed in adults, lesions may differ
in distribution and morphology, and their clinical symptoms at presentation may vary
from those reported by adult patients. The aim of this review is to describe the clinical
features and the differential diagnosis of the disease in infancy and childhood and to
examine the current approach to treatment.
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Tollefson MM, Crowson CS, McEvoy MT,
et al. Incidence of psoriasis in children: a population-
based study. J Am Acad Dermatol
2010;62(6):979-87.
2. Griffiths CE, Barker JN. Pathogenesis and
clinical features of psoriasis. Lancet 2007;
370(9583):263-71.
3. Swanbeck G, Inerot A, Martinsson T, et al.
Age at onset and different types of psoriasis.
Br J Dermatol 1995;133:768-73.
4. Nograles KE, Zaba LC, Shemer A, et al. IL-
22-producing “T22” T cells account for upregulated
IL-22 in atopic dermatitis despite reduced
IL-17-producing TH17 T cells. J Allergy
Clin Immunol 2009;123(6):1244-52.e2.
5. Girolomoni G, Mrowietz U, Paul C. Psoriasis:
rationale for targeting interleukin-17. Br J
Dermatol 2012;167(4):717-24.
6. Tsankov N, Angelova I, Kazandjieva J.
Drug-induced psoriasis. Recognition and management.
Am J Clin Dermatol 2000;1:159-
65.
7. Koebnick C, Black MH, Smith N, et al.
The association of psoriasis and elevated
blood lipids in overweight and obese children.
J Pediatr 2011;159(4):577-83.
8. Faber E, Nall M. The natural history of
psoriasis in 5600 patients. Dermatologica
1974;148:1-18.
9. Raychaudhuri SP, Gross J. A comparative
study of pediatric onset psoriasis with adult
onset psoriasis. Pediatr Dermatol 2000;17:
174-8.
10. Schafer T. Epidemiology of psoriasis. Review
and the German perspective. Dermatology
2006;212:327-37.
11. Henseler T. The genetics of psoriasis. J
Am Acad Dermatol 1997;37:S1-S11.
12. Asumalahti K, Ameen M, Suomela S, et
al. Genetic analysis of PSORS1 distinguishes
guttate psoriasis and palmoplantar pustulosis.
J Invest Dermatol 2003;120:627-32.
13. Benoit S, Hamm H. Childhood psoriasis.
Clinics in Dermatology 2007;25:555-562.
14. Nanda A, Kaur S, Kaur I, et al. Childhood
psoriasis: an epidemiologic survey of 112 patients.
Pediatr Dermatol 1990;7:19-21.
15. Steele JA, Choi C, Kwong PC. Topical tacrolimus
in the treatment of inverse psoriasis
in children. J Am Acad Dermatol 2005;53:
713-6.
16. Jury CS, McHenry P, Burden AD, et al.
Narrowband ultraviolet B (UVB) phototherapy
in children. Clin Exp Dermatol 2006;31:
196-9.
17. Di Lernia V. Phototherapy with ultraviolet
rays in paediatric dermatology. Medico e
Bambino 2007;26:237-241.
18. Kumar B, Dhar S, Handa S, et al. Methotrexate
in childhood psoriasis. Pediatr Dermatol
1994;11:271-3.
19. AAVV. The assessment and management
of psoriasis. NICE clinical guidelines,
2012.
20. Fotiadou C, Lazaridou E, Ioannides D.
Management of psoriasis in adolescence.
Adolesc Health Med Ther 2014;5:25-34.
21. Papp K, Thaçi D, Marcoux D, et al. Efficacy
and safety of adalimumab every other
week versus methotrexate once weekly in
children and adolescents with severe chronic
plaque psoriasis: a randomised, double-blind,
phase 3 trial. Lancet 2017;390(10089):40-9.
22. Paller AS, Siegfried EC, Langley RG, et
al. Etanercept treatment for children and
adolescents with plaque psoriasis. N Engl J
Med 2008;358(3):241-51.
23. Tollefson MM. Diagnosis and management
of psoriasis in children. Pediatr Clin N
Am 2014;61:261-77.
24. Au SC, Goldminz AM, Loo DS, et al. Association
between pediatric psoriasis and
the metabolic syndrome. J Am Acad Dermatol
2012;66:1012-3.
25. Ludvigsson JF, Lindelöf B, Zingone F,
Ciacci C. Psoriasis in a nationwide cohort
study of patients with celiac disease. J Invest
Dermatol 2011;131:2010-2016.
26. Torres T, Machado S, Mendonca D, Selores
M. Cardiovascular comorbidities in
childhood psoriasis. Eur J Dermatol
2014;24:229-35.
27. Augustin M, Glaeske G, Radtke MA, Christophers
E, Reich K, Schafer I. Epidemiology
and comorbidity of psoriasis in children.
Br J Dermat 2010;162(3):633-6.
28. Li SJ, Perez-Chada LM, Merola JFJ. TNF
inhibitor-induced psoriasis: proposed algorithm
for treatment and management. Psoriasis
Psoriatic Arthritis 2019;4(2):70-80.
29. Courbette O, Aupiais C, Viala J, et al. Infliximab
paradoxical psoriasis in a cohort of
children with inflammatory bowel disease. J
Pediatr Gastroenterol Nutr 2019;69(2):189-
93.
30. Eickstaedt JB, Killpack L, Tung J, Davis
D, Hand JL, Tollefson MM. Psoriasis and
psoriasiform eruptions in pediatric patients
with inflammatory bowel disease treated with
anti-tumor necrosis factor alpha agents. Pediatr
Dermatol 2017;34(3):253-60.
Corrispondenza: priscadalozzo@gmail.com